改善远程定制风险沟通与导航干预中的癌症遗传风险评估接受率:效应量大但仍有提升空间
这项三臂随机试验从科罗拉多、新泽西和新墨西哥州癌症登记处招募卵巢癌或高危乳腺癌女性,比较电话定制风险咨询与导航干预(TCN)、邮寄印刷教育(TP)和常规护理(UC)对癌症遗传风险评估(CGRA)接受率的影响。6个月时TCN组CGRA接受率为18.7%,高于TP组的3%和UC组的2.5%,TP与UC之间无显著差异。
要点
- TCN组6个月CGRA接受率18.7%,高于TP组3%(OR 7.4)和UC组2.5%(OR 8.9)。
- TP组与UC组之间CGRA接受率无显著差异。
- 常见障碍包括缺乏提供者转诊(33.7%)和费用(26.5%)。
核心结论
- 在在地理和族裔多样化的高危乳腺癌和卵巢癌生存者中,TCN提高了CGRA接受率。
- 纳入基于证据的健康传播和行为改变策略的远程个性化干预可能提高从州癌症登记处招募的女性的CGRA接受率。
研究设计与样本
- 三臂随机试验,从科罗拉多、新泽西和新墨西哥州癌症登记处招募卵巢癌或高危乳腺癌女性。
- 参与者被分配至TP组(邮寄教育手册)、TCN组(邮寄教育手册、由健康教练进行的初始电话心理教育课程、随访信和随访导航电话)或UC组。
- 参与者平均年龄61岁,25.4%为西班牙裔,5.9%为非西班牙裔黑人,17.5%居住在农村地区。
主要发现
- 6个月时,TCN组18.7%的女性接受了CGRA,高于TP组的3%(OR 7.4,95%CI 3.0至18.3,P<.0001)。
- 6个月时,TCN组18.7%的女性接受了CGRA,高于UC组的2.5%(OR 8.9,95%CI 3.4至23.5,P<.0001)。
- TP组与UC组之间CGRA接受率无显著差异。
- 遗传咨询常见障碍为缺乏提供者转诊(33.7%)和费用(26.5%)。
- 遗传检测障碍为预期难以应对检测结果(14.0%)和费用(41.2%)。
关键数值与推荐
- 卵巢癌或高危乳腺癌女性推荐接受癌症遗传风险评估(CGRA),但少于30%接受推荐遗传服务,服务不足人群中接受率最低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Cancer genetic risk assessment (CGRA) is recommended for women with ovarian cancer or high-risk breast cancer, yet fewer than 30% receive recommended genetic services, with the lowest rates among underserved populations. We hypothesized that compared with usual care (UC) and mailed targeted print (TP) education, CGRA uptake would be highest among women receiving a phone-based tailored risk counseling and navigation intervention (TCN). METHODS: In this three-arm randomized trial, women with ovarian or high-risk breast cancer were recruited from statewide cancer registries in Colorado, New Jersey, and New Mexico. Participants assigned to TP received a mailed educational brochure. Participants assigned to TCN received the mailed educational brochure, an initial phone-based psychoeducational session with a health coach, a follow-up letter, and a follow-up navigation phone call. RESULTS: Participants' average age was 61 years, 25.4% identified as Hispanic, 5.9% identified as non-Hispanic Black, and 17.5% lived in rural areas. At 6 months, more women in TCN received CGRA (18.7%) than those in TP (3%; odds ratio, 7.4; 95% CI, 3.0 to 18.3; P < .0001) or UC (2.5%; odds ratio, 8.9; 95% CI, 3.4 to 23.5; P < .0001). There were no significant differences in CGRA uptake between TP and UC. Commonly cited barriers to genetic counseling were lack of provider referral (33.7%) and cost (26.5%), whereas anticipated difficulty coping with test results (14.0%) and cost (41.2%) were barriers for genetic testing. CONCLUSION: TCN increased CGRA uptake in a group of geographically and ethnically diverse high-risk breast and ovarian cancer survivors. Remote personalized interventions that incorporate evidence-based health communication and behavior change strategies may increase CGRA among women recruited from statewide cancer registries.
引用
- Kinney AY, Walters ST, Lin Y, et al. Improving Uptake of Cancer Genetic Risk Assessment in a Remote Tailored Risk Communication and Navigation Intervention: Large Effect Size but Room to Grow. J Clin Oncol. 2023. PMID: 36787512. doi:10.1200/JCO.22.00751
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。